Phantom Neuro, which develops sensors to control prosthetic limbs, is seeking roughly $30 million in Series B financing, CEO Connor Glass tells Axios Pro exclusively.
Why it matters: The funding will help Phantom Neuro advance its implantable sensor into clinical trials ahead of FDA approval and commercialization.
